Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/195.11
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Conjugate or complex > Conjugate or complex includes hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof
Description: Subject matter wherein at least one component of the conjugate or complex is a hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof.










Patents under this class:
1 2 3 4 5 6

Patent Number Title Of Patent Date Issued
8685406 Compositions of and method of using heat shock protein peptides Apr. 1, 2014
8637042 Targeted particles and methods of using the same Jan. 28, 2014
8617532 Therapeutic use of interferon-polymer conjugates Dec. 31, 2013
8604127 Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof Dec. 10, 2013
8563003 Method for the treatment of malignant and infectious chronic diseases Oct. 22, 2013
8551494 Methods of immune modulation with death receptor-induced apoptosis Oct. 8, 2013
8529899 Human growth hormone immunoglobulin fusion proteins Sep. 10, 2013
8524244 Targeted therapeutics based on engineered proteins that bind EGFR Sep. 3, 2013
8524864 Method for producing conjugate of thyroxine and albumin Sep. 3, 2013
8476230 Insulinotropic complex using an immunoglobulin fragment Jul. 2, 2013
8383129 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability Feb. 26, 2013
8372388 Method for preparing a stable TNF-.alpha. vaccine Feb. 12, 2013
8329191 Three-branched polyethylene glycol-G-CSF conjugate Dec. 11, 2012
8273343 Protein-polymer conjugates Sep. 25, 2012
8263084 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate Sep. 11, 2012
8252835 Compounds and methods for treating estrogen receptor-related diseases Aug. 28, 2012
8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors Jul. 24, 2012
8158132 Clostridial toxin derivatives able to modify peripheral sensory afferent functions Apr. 17, 2012
8148331 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof Apr. 3, 2012
8092812 Methods and compositions for immunization against chlamydial infection and disease Jan. 10, 2012
8025886 Modified VEGF-A with improved angiogenic properties Sep. 27, 2011
7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use Jun. 14, 2011
7956034 FSH glycosylation variant D3N Jun. 7, 2011
7939080 HER-2 binding antagonists May. 10, 2011
7935350 Ii-key/Her-2/neu hybrid cancer vaccine May. 3, 2011
7927602 Fas ligand-avidin/streptavidin fusion proteins Apr. 19, 2011
7906118 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology Mar. 15, 2011
7892567 Methods and compositions for immunization against chlamydial infection and disease Feb. 22, 2011
7887811 Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF.alpha. and a carrier protein Feb. 15, 2011
7858765 OX40R binding agents Dec. 28, 2010
7807134 Multidrug multiligand conjugates for targeted drug delivery Oct. 5, 2010
7790174 G-CSF polypeptides and uses thereof Sep. 7, 2010
7758852 OX40R binding agents Jul. 20, 2010
7713533 Active complex of .alpha.-lactalbumin (HAMLET) and cofactor May. 11, 2010
7709603 PRO1190 polypeptides May. 4, 2010
7700113 Inhibiting breast cancer cell growth by administering an intracellular domain of NOTCH2 Apr. 20, 2010
7695722 Methods for reducing GNRH-positive tumor cell replication Apr. 13, 2010
7678378 Compounds for intracellular delivery of therapeutic moieties to nerve cells Mar. 16, 2010
7670595 Fc-interferon-beta fusion proteins Mar. 2, 2010
7659368 ErbB2 and ErbB3 chimeric heteromultimer adhesins Feb. 9, 2010
7635592 Tissue engineering scaffolds promoting matrix protein production Dec. 22, 2009
7612034 Treatment of subnormal bone mineral density Nov. 3, 2009
7585509 Erb-2 receptor targeting peptide Sep. 8, 2009
7563760 P-selectin ligand protein Jul. 21, 2009
7560101 Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A Jul. 14, 2009
7557195 Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF Jul. 7, 2009
7553490 Vaccines against Escherichia coli O157 infection Jun. 30, 2009
7541040 Chimeric molecule for the treatment of th2-like cytokine mediated disorders Jun. 2, 2009
7534866 Methods and compositions for generating bioactive assemblies of increased complexity and uses May. 19, 2009
7521056 Stably tethered structures of defined compositions with multiple functions or binding specificities Apr. 21, 2009

1 2 3 4 5 6










 
 
  Recently Added Patents
Multi-state DC-DC converter having undirectional switches
Methods, systems, and physical computer storage media for processing a plurality of input/output request jobs
Hemostatic devices and methods of making same
Method and system for shared high speed cache in SAS switches
Process information structuring support method
System for determining potential lot consolidation during manufacturing
Vehicle driving assistance apparatus
  Randomly Featured Patents
Method of canceling noise contained in received signal
Disk drive spindle motor with externally mounted flux concentrator ring
Chip layout of semiconductor integrated circuit
Method and apparatus for dynamic data flow control using prioritization of data requests
Protein skimmer and power head thereof
Water loss reduction agents
Process for the production of cement in a fluidized bed
Filled resin compositions and articles made therefrom
Process for reduced emitter-base capacitance in bipolar transistor
Process for the synthesis of propargyl alcohols and their use for production of prostaglandin precursors